Gabapentin Market Regional Analysis:
North American Market Insights
The gabapentin market in the North America industry is estimated to dominate majority revenue share of 35% by 2035. The growth can be ascribed to the growing prevalence of chronic pain conditions in the region. As the medication is used to treat anxiety, bipolar disorder, nausea, and other off-label indications. It is high in demand in the United States and Canada from this region. As per the data, gabapentin is highly prescribed and is one of the top 30 medications in the United States.
APAC Market Insights
The Asia Pacific gabapentin market is poised to account for a significant market value during the forecast timeframe. The growing awareness about the benefits of gabapentin over opioids and increasing healthcare spending in the region is the primary factor boosting the market expansion in the region. Moreover, various other factors such as the growing geriatric population, rise in government initiatives, research and development by pharmaceutical industries, and increasing product approvals are expected to elevate the growth of the gabapentin market in the region.
